AU2003303953B2 - Antibacterial pyrazole carboxylic acid hydrazides - Google Patents

Antibacterial pyrazole carboxylic acid hydrazides Download PDF

Info

Publication number
AU2003303953B2
AU2003303953B2 AU2003303953A AU2003303953A AU2003303953B2 AU 2003303953 B2 AU2003303953 B2 AU 2003303953B2 AU 2003303953 A AU2003303953 A AU 2003303953A AU 2003303953 A AU2003303953 A AU 2003303953A AU 2003303953 B2 AU2003303953 B2 AU 2003303953B2
Authority
AU
Australia
Prior art keywords
substituted
unsubstituted
group
alkyl
alkynyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
AU2003303953A
Other languages
English (en)
Other versions
AU2003303953A1 (en
Inventor
Michelle M. Bu tler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbiotix Inc
Original Assignee
Microbiotix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbiotix Inc filed Critical Microbiotix Inc
Publication of AU2003303953A1 publication Critical patent/AU2003303953A1/en
Application granted granted Critical
Publication of AU2003303953B2 publication Critical patent/AU2003303953B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/56—1,2-Diazoles; Hydrogenated 1,2-diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dermatology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003303953A 2002-09-10 2003-09-10 Antibacterial pyrazole carboxylic acid hydrazides Expired - Fee Related AU2003303953B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40943902P 2002-09-10 2002-09-10
US60/409,439 2002-09-10
PCT/US2003/028392 WO2004094370A2 (en) 2002-09-10 2003-09-10 Antibacterial pyrazole carboxylic acid hydrazides

Publications (2)

Publication Number Publication Date
AU2003303953A1 AU2003303953A1 (en) 2004-11-19
AU2003303953B2 true AU2003303953B2 (en) 2007-10-04

Family

ID=33309471

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003303953A Expired - Fee Related AU2003303953B2 (en) 2002-09-10 2003-09-10 Antibacterial pyrazole carboxylic acid hydrazides

Country Status (6)

Country Link
US (1) US20060258729A1 (cg-RX-API-DMAC10.html)
EP (1) EP1549143A2 (cg-RX-API-DMAC10.html)
JP (1) JP2006508178A (cg-RX-API-DMAC10.html)
AU (1) AU2003303953B2 (cg-RX-API-DMAC10.html)
CA (1) CA2497410A1 (cg-RX-API-DMAC10.html)
WO (1) WO2004094370A2 (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006017505A2 (en) * 2004-08-04 2006-02-16 Schering Corporation Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases
US7786139B2 (en) 2006-11-21 2010-08-31 Omeros Corporation PDE10 inhibitors and related compositions and methods
WO2011031935A1 (en) * 2009-09-11 2011-03-17 Glsynthesis Inc. Selective antibacterials for clostridium difficile infections
WO2014059429A2 (en) * 2012-10-12 2014-04-17 Health Research, Inc. Small molecules inhibiting oncoprotein myc
US20240139191A1 (en) * 2020-12-14 2024-05-02 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Small molecules as larp1 ligands
UY39882A (es) * 2021-08-02 2023-06-15 Eurofarma Laboratorios S A COMPUESTOS NACILHIDRAZÓNICOS INHIBIDORES DE Nav 1.7 Y/O Nav 1.8, SUS PROCESOS DE OBTENCIÓN, COMPOSICIONES, USOS, MÉTODOS DE TRATAMIENTO DE ESTOS Y KITS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7232685B2 (en) * 2001-12-19 2007-06-19 The Regents Of The Universtiy Of California Cell lines with latent immunodeficiency virus and methods of use thereof
WO2003105840A2 (en) * 2002-06-17 2003-12-24 The Pennsylvania State Research Foundation Sphingosine kinase inhibitors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MILYUTIN A. V. ET AL., Khimiko-Farmatsevticheskii Zhurnal., vol. 32, no. 8, pages 24-26 ( 1998) *

Also Published As

Publication number Publication date
EP1549143A2 (en) 2005-07-06
AU2003303953A1 (en) 2004-11-19
WO2004094370A3 (en) 2005-03-03
WO2004094370A2 (en) 2004-11-04
CA2497410A1 (en) 2004-11-04
US20060258729A1 (en) 2006-11-16
JP2006508178A (ja) 2006-03-09

Similar Documents

Publication Publication Date Title
ES2331250T3 (es) Inhibidores de la girasa bacteriana y usos de los mismos.
RU2609259C2 (ru) Пиримидиновые ингибиторы гиразы и топоизомеразы iv
US20040224981A1 (en) Antibacterial methods and compositions
Stein The 4‐Quinolone Antibiotics: Past, Present, and Future
KR101519675B1 (ko) 균막 형성을 처리하기 위한 트리아졸 화합물
ES2986675T3 (es) Bacteriófago para el tratamiento y la prevención de cánceres asociados a bacterias
US9540389B2 (en) Antimicrobial potentiators
US20230330065A1 (en) RelA Inhibitors for Biofilm Disruption
KR20150089086A (ko) 박테리아 감염을 치료하기 위한 조성물 및 방법
US11731946B2 (en) Broad spectrum antivirulence, anti-persistence compounds
US12016874B2 (en) Methods and compositions for treating carbapenem-resistant klebsiella pneumoniae infections
US12622919B2 (en) Methods for treating hypervirulent Klebsiella pneumoniae infection
US20060258729A1 (en) Antibacterial pyrazole carboxylic acid hydrazides
JP2001526060A (ja) 抗感染症薬としての酵素プロドラッグの適用
US20150087614A1 (en) Methods and compositions for reducing the proliferation of gram positive bacteria
JP7823077B2 (ja) 抗菌化合物
CN110215445B (zh) 香草酸在抑制多重耐药霍氏肠杆菌生长中的应用
CN117545485A (zh) 抗菌化合物
CN116063227A (zh) 截短侧耳素衍生物及其合成方法和应用
CN121622671B (zh) 美罗培南或氨曲南与萘啶酸联用在制备抗菌药物中的应用
Dalhoff Interaction of Quinolones with Host—Parasite Relationship
JP2010519301A (ja) 感染を処置する方法
MXPA02008368A (es) Ectatm antiinfeccioso.
CN121622905A (zh) 用于治疗细菌感染的药物组合物
WO2026015688A1 (en) Compositions and methods for treating bacterial disease

Legal Events

Date Code Title Description
MK25 Application lapsed reg. 22.2i(2) - failure to pay acceptance fee